title: CUA-CUOG guidelines for the management of castration-resistant prostate cancer (CRPC): 2013 update.
authors.affiliation: Division of Urologic Oncology Centre Hospitalier de l'Université de Montréal, Montréal, QC;
authors.forename: Fred
authors.initials: F
authors.lastname: Saad
authors.forename: Sebastien
authors.initials: S
authors.lastname: Hotte
authors.forename: Charles
authors.initials: C
authors.lastname: Catton
authors.forename: Darrel
authors.initials: D
authors.lastname: Drachenberg
authors.forename: Antonio
authors.initials: A
authors.lastname: Finelli
authors.forename: Neil
authors.initials: N
authors.lastname: Fleshner
authors.forename: Martin
authors.initials: M
authors.lastname: Gleave
authors.forename: Anil
authors.initials: A
authors.lastname: Kapoor
authors.forename: Wassim
authors.initials: W
authors.lastname: Kassouf
authors.forename: Andrew
authors.initials: A
authors.lastname: Loblaw
authors.forename: Scott
authors.initials: S
authors.lastname: North
authors.forename: Nawaid
authors.initials: N
authors.lastname: Usmani
authors.forename: Kim N
authors.initials: KN
authors.lastname: Chi
references.citation: N Engl J Med. 2013 Jan 10;368(2):138-48
references.pmid: 23228172
references.citation: Lancet. 2012 Jan 7;379(9810):39-46
references.pmid: 22093187
references.citation: N Engl J Med. 2004 Oct 7;351(15):1513-20
references.pmid: 15470214
references.citation: Lancet. 2010 Oct 2;376(9747):1147-54
references.pmid: 20888992
references.citation: J Clin Oncol. 2008 Mar 1;26(7):1148-59
references.pmid: 18309951
references.citation: BJU Int. 2010 Oct;106(7):974-8
references.pmid: 20230389
references.citation: Urology. 2006 Jun;67(6):1235-40
references.pmid: 16765185
references.citation: J Urol. 2003 Jun;169(6):2008-12
references.pmid: 12771706
references.citation: Cancer. 2006 Mar 1;106(5):1041-6
references.pmid: 16456811
references.citation: Cancer. 2004 Mar 1;100(5):892-9
references.pmid: 14983482
references.citation: Arch Pharm (Weinheim). 2002 Apr;335(4):119-28
references.pmid: 12112031
references.citation: Lancet. 2011 Mar 5;377(9768):813-22
references.pmid: 21353695
references.citation: Eur Urol. 2003 Nov;44(5):519-26
references.pmid: 14572748
references.citation: BJU Int. 2009 Feb;103(4):434-40
references.pmid: 19154462
references.citation: J Clin Oncol. 2010 Sep 20;28(27):4247-54
references.pmid: 20733135
references.citation: Can J Urol. 2006 Dec;13(6):3335-9
references.pmid: 17187697
references.citation: J Clin Oncol. 2010 Mar 1;28(7):1099-105
references.pmid: 20100959
references.citation: Cancer. 1995 Jul 1;76(1):96-100
references.pmid: 8630883
references.citation: Clin Cancer Res. 2004 Jan 15;10(2):440-8
references.pmid: 14760063
references.citation: Semin Oncol. 1993 Jun;20(3 Suppl 2):38-43
references.pmid: 7684865
references.citation: N Engl J Med. 2011 May 26;364(21):1995-2005
references.pmid: 21612468
references.citation: N Engl J Med. 2004 Oct 7;351(15):1502-12
references.pmid: 15470213
references.citation: N Engl J Med. 2001 Sep 27;345(13):948-55
references.pmid: 11575286
references.citation: J Clin Oncol. 2005 May 1;23(13):2918-25
references.pmid: 15860850
references.citation: Lancet Oncol. 2012 Oct;13(10):983-92
references.pmid: 22995653
references.citation: J Natl Cancer Inst. 2004 Jun 2;96(11):879-82
references.pmid: 15173273
references.citation: N Engl J Med. 2005 Jan 13;352(2):154-64
references.pmid: 15647578
references.citation: N Engl J Med. 2012 Sep 27;367(13):1187-97
references.pmid: 22894553
references.citation: N Engl J Med. 2009 Aug 20;361(8):745-55
references.pmid: 19671656
references.citation: Science. 2009 May 8;324(5928):787-90
references.pmid: 19359544
references.citation: J Clin Oncol. 2004 Mar 15;22(6):1025-33
references.pmid: 15020604